Novartis Tagged With Anti-monopoly Conditions In China For Alcon Acquisition
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - China's growing assertiveness in commercial matters is becoming evident in its influence on merger and acquisitions matters and its willingness to impose conditions under its two-year-old anti-monopoly law